ACCESS Newswire
12 May 2022, 11:43 GMT+10
ALLSHWIL, SWITZERLAND / ACCESSWIRE / May 12, 2022 / Spexis AG (SIX: SPEX) today announced that that the company will present at BioEquity Europe, taking place May 17 & 18, 2022. Jeff Wager, CEO of Spexis, will provide an overview of the company and its pipeline and will be available to participate in one-on-one meetings with investors who are registered to attend the conference.
The presentation is now available to conference registrants. For more information on the conference, visit the BioEquity website .
For further information please contact:
For Investors:
Hernan Levett
Chief Financial Officer
Spexis AG.
+41 61 567 16 00
[email protected]
Raimund Gabriel
MC Services
[email protected]
Ph: +49 89 210 228 0
For Media:
Dr. Stephan Feldhaus
Feldhaus & Partner
+41 79 865 92 56
[email protected]
Dr. Brigitte Keller/Laurie Doyle
MC Services
[email protected]
Europe: +49 89 210 228 0
U.S.: +1 339 832 0752
About Spexis
Spexis is a clinical-stage biopharmaceutical company based in Allschwil, Switzerland, focused on rare diseases and oncology. The current pipeline of the company is a combination of two legacy companies, Polyphor AG and EnBiotix, Inc. (Boston, MA, USA) which merged in December 2021. The combined company has been renamed to Spexis AG and is trading on the SIX Swiss Exchange under the symbol SIX:SPEX. For further information please visit: www.spexisbio.com .
Disclaimer
This press release contains forward-looking statements which are based on current assumptions and forecasts of Spexis management. Known and unknown risks, uncertainties, and other factors could lead to material differences between the forward-looking statements made here and the actual development, in particular Spexis' results, financial situation, and performance. Readers are cautioned not to put undue reliance on forward-looking statements, which speak only as of the date of this communication. Spexis disclaims any intention or obligation to update and revise any forward-looking statements, whether as a result of new information, future events or otherwise.
SOURCE: Polyphor AG
Get a daily dose of Chicago Chronicle news through our daily email, its complimentary and keeps you fully up to date with world and business news as well.
Publish news of your business, community or sports group, personnel appointments, major event and more by submitting a news release to Chicago Chronicle.
More InformationWASHINGTON, D.C.: Filmmaker Peter Jackson's lifelong fascination with the extinct giant New Zealand flightless bird called the moa...
NEW DELHI, India: India has submitted a revised proposal to the World Trade Organization (WTO) in Geneva to implement retaliatory tariffs...
SAN FRANCISCO, California: Nvidia, the Silicon Valley chipmaker at the heart of the artificial intelligence boom, this week briefly...
REDMOND, Washington: Artificial intelligence is transforming Microsoft's bottom line. The company saved over US$500 million last year...
WASHINGTON, D.C.: A federal rule designed to make it easier for Americans to cancel subscriptions has been blocked by a U.S. appeals...
BASTROP, Texas: In a surprising turn at Elon Musk's X platform, CEO Linda Yaccarino announced she is stepping down, just months after...
WASHINGTON, D.C.: An elaborate impersonation scheme involving artificial intelligence targeted senior U.S. and foreign officials in...
(Photo credit: David Richard-Imagn Images) In a span of 10 pitches Saturday, the Cincinnati Reds ensured they wouldn't be swept for...
(Photo credit: Eric Canha-Imagn Images) In his 51st career start, Garrett Crochet accomplished two feats in one dominant outing:...
(Photo credit: Matt Marton-Imagn Images) Anders Dreyer recorded a first-half brace, and Western Conference-leading San Diego FC withstood...
(Photo credit: Stan Szeto-Imagn Images) SONOMA, Calif. - In closing laps of the Pit Boss/FoodMaxx 250 at Sonoma Raceway, the pupil...
(Photo credit: Patrick Gorski-Imagn Images) Kyle Manzardo hit a go-ahead solo home run in the sixth inning and Tanner Bibee earned...